Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Heymann

Showing results (101-110 of 243) with videos related to

Pageof 25
Sort By:
Oncology Reports|November 6, 2007
Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cellsKanji Mori, Martine Berreur, Fréderic Blanchard, et al.
Bone|September 7, 2014
Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignanciesFrédéric Lézot, Julie Chesneau, Séverine Battaglia, et al.
Scientific Reports|May 4, 2018
Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3ADaniëlle de Ridder, Silvia Marino, Ryan T Bishop, et al.
Mediators of Inflammation|December 9, 2014
IL-1β and TNFα promote monocyte viability through the induction of GM-CSF expression by rheumatoid arthritis synovial fibroblastsChristelle Darrieutort-Laffite, Marie-Astrid Boutet, Mathias Chatelais, et al.
Acta Biomaterialia|September 9, 2014
Osteoblastic and osteoclastic differentiation of human mesenchymal stem cells and monocytes in a miniaturized three-dimensional culture with mineral granulesAnne Laure Gamblin, Audrey Renaud, Céline Charrier, et al.
Drug Discovery Today|November 30, 2018
Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?Hannah K Brown, Marta Tellez-Gabriel, Pierre-François Cartron, et al.
Frontiers in Bioengineering and Biotechnology|October 23, 2023
Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurementsCamille Jubelin, Javier Muñoz-Garcia, Denis Cochonneau, et al.
Epigenomics|January 10, 2020
Cell-free circulating epimarks in cancer monitoringManon Duforestel, Joséphine Briand, Gwenola Bougras-Cartron, et al.
The American Journal of Pathology|October 28, 2003
Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysisEva Grimaud, Luc Soubigou, Séverine Couillaud, et al.
The Journal of Pathology|March 2, 2010
Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesisMarc Baud'huin, Romain Renault, Céline Charrier, et al.
Pageof 25

Showing results (101-110 of 243) with videos related to

Sort By:
Pageof 25
Oncology Reports|November 6, 2007
Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cellsKanji Mori, Martine Berreur, Fréderic Blanchard, et al.
Bone|September 7, 2014
Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignanciesFrédéric Lézot, Julie Chesneau, Séverine Battaglia, et al.
Scientific Reports|May 4, 2018
Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3ADaniëlle de Ridder, Silvia Marino, Ryan T Bishop, et al.
Mediators of Inflammation|December 9, 2014
IL-1β and TNFα promote monocyte viability through the induction of GM-CSF expression by rheumatoid arthritis synovial fibroblastsChristelle Darrieutort-Laffite, Marie-Astrid Boutet, Mathias Chatelais, et al.
Acta Biomaterialia|September 9, 2014
Osteoblastic and osteoclastic differentiation of human mesenchymal stem cells and monocytes in a miniaturized three-dimensional culture with mineral granulesAnne Laure Gamblin, Audrey Renaud, Céline Charrier, et al.
Drug Discovery Today|November 30, 2018
Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?Hannah K Brown, Marta Tellez-Gabriel, Pierre-François Cartron, et al.
Frontiers in Bioengineering and Biotechnology|October 23, 2023
Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurementsCamille Jubelin, Javier Muñoz-Garcia, Denis Cochonneau, et al.
Epigenomics|January 10, 2020
Cell-free circulating epimarks in cancer monitoringManon Duforestel, Joséphine Briand, Gwenola Bougras-Cartron, et al.
The American Journal of Pathology|October 28, 2003
Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysisEva Grimaud, Luc Soubigou, Séverine Couillaud, et al.
The Journal of Pathology|March 2, 2010
Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesisMarc Baud'huin, Romain Renault, Céline Charrier, et al.
Pageof 25